Buy Actemra Infusion 80 mg/4 mL 1 Vialx4 mL Online At Best Price In Pakistan

Dosage

Missed Dose

Infusion: Since this medicine is usually administered by a qualified healthcare professional in the clinical/hospital setting, the likelihood of a missed dose is very low. Subcutaneous injection: Administer the missed dose as soon as you remember. If it is almost time for your next dose, skip the missed dose. Do not double your dose to make up for the missed one.

Overdose

Infusion: Since this medicine is administered in the hospital setting by a qualified healthcare professional, the likelihood of an overdose is very low. However, emergency medical treatment will be initiated by the doctor if an overdose is suspected. Subcutaneous injection: Seek emergency medical treatment or contact the doctor in case of an overdose.

Interactions

Live vaccines   (severe)

Adalimumab   (severe)

Amlodipine   (moderate)

Phenytoin   (moderate)

Theophylline   (moderate)

Cyclosporine   (moderate)

Warfarin   (moderate)

Atorvastatin   (severe)

Prescribes

Rheumatoid Arthritis

This medicine is indicated for the treatment of rheumatoid arthritis, an immune disorder characterized by pain and swelling of joints. It is normally used when other disease-modifying anti-rheumatoid medications are not effective.

Giant cell arteritis

This medicine is indicated for the treatment of giant cell arteritis, a condition where blood vessels, particularly in the head and scalp area, become swollen.

Polyarticular juvenile idiopathic arthritis

This medicine is indicated for the treatment of polyarticular juvenile idiopathic arthritis, an arthritic condition in children characterized by swollen and painful joints. It should only be used in children aged 2 years or above.

Systemic juvenile idiopathic arthritis

This medicine is indicated for the treatment of systemic juvenile idiopathic arthritis, an inflammatory condition causing fever, pain, swelling, and developmental abnormalities of different parts of the body in children aged 2 years and above.

Cytokine release syndrome

This medicine is used for the treatment of cytokine release syndrome, a severe and life-threatening reaction that usually develops after receiving certain immunotherapy medications via infusion.

Side Effects

Mild fever and chills  

High blood pressure  

Skin rash and itching  

Headache  

Flu like symptoms   (severe)

Sore throat  

Nausea and Vomiting  

Stomach pain  

Constipation  

Mouth blisters  

Joint pain   (severe)

Difficult and painful breathing   (severe)

Severe light-headedness   (severe)

Severe skin rash and hives   (severe)

Black or tarry stools   (severe)

Bloody or coffee colored vomit   (severe)

Blurred vision   (severe)

Bloody or cloudy urine   (severe)

Change in heart rate   (severe)

Unusual bleeding or bruising   (severe)

Loss of appetite  

Injection site bruising and red coloration  

Loss of consciousness   (severe)

Skin blistering  

Diarrhea  

Warnings

Low blood cell counts

Elevated liver enzymes

Lipid abnormalities

Immune suppression

Vaccinations

Other medicines

Heart diseases

Driving or operating machinery

Intravenous administration

Pregnancy

Breast-feeding

When Not To Use

Allergy

This medicine is not recommended for use in patients with a known allergy to Actemra Infusion 80 mg/4 mL 1 Vialx4 mL or any other inactive ingredients present along in the formulation. It is also not recommended for use if you have a history of allergy to any other recombinant human or humanized antibodies or proteins that are of hamster origin.

Active severe infection

This medicine is not recommended for use in patients suffering from an active severe infection due to the increased risk of worsening of the patient's condition.